Seminars in Oncology
Volume 29, Issue 3 , Pages 231-245, June 2002

c-erbB-2 in breast cancer: Development of a clinically useful marker☆☆☆

Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Department of Medicine, University of Michigan Medical Center, Ann Arbor, MI; and Department of Pathology, Oklahoma University Center for Health Sciences, Tulsa, OK.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Supported by the Fashion Footwear Association of New York/Shoes on Sale (D.F.H.) and the Lloyd Rader Endowed Chair, University of Oklahoma College of Medicine (A.T.).

☆☆ Address reprint requests to Daniel F. Hayes, MD, CCGC 6312, 1500 E Medical Center Dr, Ann Arbor, MI 48104.

PII: S0093-7754(02)50179-2

doi:10.1053/sonc.2002.32899

Seminars in Oncology
Volume 29, Issue 3 , Pages 231-245, June 2002

Article Tools

* Image Usage & Resolution